International Patent: CANNABINOID ORAL DOSAGE FORMS COMPRISING HYDROXYPROPYL BETA-CYCLODEXTRIN, POLOXAMER, AND A POWDERED CARRIER

GENEVA, Nov. 6 -- ESOLATE PHARMACEUTICALS LTD filed a patent application (IB2026/054350) for “CANNABINOID ORAL DOSAGE FORMS COMPRISING HYDROXYPROPYL BETA-CYCLODEXTRIN, POLOXAMER, AND A POWDERED CARRIER”. With publication no. WO/2026/229951, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/69

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....